CD4+ T cells are trigger and target of the glucocorticoid response that prevents lethal immunopathology in toxoplasma infection
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Synthetic glucocorticoids (GCs) are commonly used in the treatment of inflammatory diseases, but the role of endogenous GCs in the regulation of host-protective immune responses is poorly understood. Here we show that GCs are induced during acute Toxoplasma gondii infection and directly control the T cell response to the parasite. When infected with toxoplasma, mice that selectively lack GC receptor (GR) expression in T cells (GRlck-Cre) rapidly succumb to infection despite displaying parasite burdens indistinguishable from control animals and unaltered levels of the innate cytokines IL-12 and IL-27. Mortality in the GRlck-Cre mice was associated with immunopathology and hyperactive Th1 cell function as revealed by enhanced IFN-γ and TNF production in vivo. Unexpectedly, these CD4+ T lymphocytes also overexpressed IL-10. Importantly, CD4+ T cell depletion in wild-type or GRlck-Cre mice led to ablation of the GC response to infection. Moreover, in toxoplasma-infected RAG−/− animals, adoptive transfer of CD4+ T lymphocytes was required for GC induction. These findings establish a novel IL-10–independent immunomodulatory circuit in which CD4+ T cells trigger a GC response that in turn dampens their own effector function. In the case of T. gondii infection, this self-regulatory pathway is critical for preventing collateral tissue damage and promoting host survival.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens
Sternberg, E. M. (2006) · Nature Reviews Immunology · doi:10.1038/nri1810 · Cited by 1,064
Jamieson, A. M., Yu, S., Annicelli, C. H., & Medzhitov, R. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.01.010 · Cited by 180
Liu, F., & Whitton, J. L. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.10.5936 · Cited by 149 · cited 1×
“On day 8 after infection, mice were injected i.p. with BFA (Sigma-Aldrich; 250 µg/0.5 ml PBS; Liu and Whitton, 2005) or i.v. with the T. gondii–specific AS15 peptide (25 µg/0.2 ml PBS).”
Influential
Cited by
The HPA – Immune Axis and the Immunomodulatory Actions of Glucocorticoids in the Brain
Bellavance, M.-A., & Rivest, S. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00136 · Cited by 419
“Accordingly, the targeted disruption of the GR in T cells (GRlkc-Cre mice) produced hyperactive Th1 cells and increased mortality upon infection (51) while it precipitated the onset of disease in a murine model of multiple sclerosis (experimental autoimmune encephalomyelitis) (52).”
BackgroundControl of immunity by glucocorticoids in health and disease
Shimba, A., & Ikuta, K. (2020) · Seminars in Immunopathology · doi:10.1007/s00281-020-00827-8 · Cited by 183
Clark, J. T., Weizman, O.-E., Aldridge, D. L., Shallberg, L. A., Eberhard, J., Lanzar, Z., Wasche, D., Huck, J. D., Zhou, T., Ring, A. M., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112147 · Cited by 20
Shimba, A., Cui, G., Abe, S., Hirota, K., Miyauchi, E., Takami, D., Tani-ichi, S., Kato, R., Tajima, M., Kanahashi, T., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116093 · Cited by 15
Metadata
- Authors
- Kugler, D. G., Mittelstadt, P. R., Ashwell, J. D., Sher, A., & Jankovic, D.
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2013-08-26
- Volume
- 210
- Issue
- 10
- Pages
- 1919-1927
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2134436187
- Cited by
- 60
- References
- 3
- FWCI
- 3.06
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.